Tag Stem cells
The technique that helped revolutionize modern biology by making the mouse a crucible of genetic manipulation and a window to human disease has been extended to human embryonic stem (ES) cells.
The Wisconsin Alumni Research Foundation has signed two licensing agreements allowing a company and another university to distribute human embryonic stem cells in research.
Using stem cells as a window to the earliest developmental processes in the human brain, scientists have found that a group of genes critical for brain development is selectively disrupted in Down syndrome.
The Wisconsin Alumni Research Foundation and Geron Corporation today announced an agreement for the commercialization of human embryonic stem cell technology.
In a set of meticulous experiments, scientists have demonstrated the ability of human embryonic stem cells to develop into nascent brain cells and, seeded into the intact brains of baby mice, further develop into healthy, functioning neural cells.
A portion of the funds received by the State of Wisconsin in a price-fixing settlement with vitamin manufacturers has been directed toward stem cell research at UW–Madison.
The National Institutes of Health and the WiCell Research Institute, Inc., of Madison announced today, Sept. 5, the signing of a Memorandum of Understanding for research use of WiCell's existing five human embryonic stem cell lines.
For the first time, scientists have demonstrated that undifferentiated human embryonic stem cells can be teased down a developmental pathway to become blood cells.
In an effort to move human embryonic stem cell technology into the mainstream of academic and corporate research, the Wisconsin Alumni Research Foundation has established a private subsidiary whose primary purpose will be to distribute the cells to qualified scientists.
The dream of one day being able to grow in the laboratory an unlimited amount of human tissues for transplantation is one step closer to reality.